Clinical Trials Sponsored by Theravant Corporation
Total 6538 results
-
Spectranetics CorporationCompletedPeripheral Arterial Disease | Peripheral Vascular Disease
-
OliPass CorporationCompleted
-
Irrimax CorporationTerminatedAbscess | Skin and Soft Tissue InfectionsUnited States
-
Yuhan CorporationActive, not recruitingEGFR Gene MutationKorea, Republic of
-
Candela CorporationWithdrawn
-
Omeros CorporationCompletedThrombotic MicroangiopathiesUnited States, Belgium, Bulgaria, Hong Kong, Italy, Lithuania, Malaysia, New Zealand, Poland, Singapore, Taiwan, Thailand
-
Amorepacific CorporationCompletedRespiratory Conditions Due to Unspecified External AgentKorea, Republic of
-
Masimo CorporationTerminatedRegional Saturation of Oxygen (rSO2)United States
-
Erchonia CorporationCompletedSensorineural Hearing LossUnited States
-
Masimo CorporationTerminated
-
Vericel CorporationCompletedArticular Cartilage DefectNetherlands, Norway, France, Czechia, Sweden, Poland, United Kingdom
-
Vericel CorporationTerminatedPseudarthrosis | Fracture, UnunitedUnited States
-
Vericel CorporationTerminatedSingle Level Posterolateral Spinal Fusion
-
Glaukos CorporationCompletedKeratoconusUnited States
-
Glaukos CorporationWithdrawn
-
Glaukos CorporationTerminatedKeratoconusUnited States
-
Incyte CorporationCompletedProspective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)MPN (Myeloproliferative Neoplasms)United States, Puerto Rico
-
Glaukos CorporationCompletedKeratoconusUnited States
-
Glaukos CorporationCompletedProgressive KeratoconusUnited States
-
Glaukos CorporationTerminatedHyperopia | Hyperopic AstigmatismUnited States
-
Glaukos CorporationActive, not recruiting
-
Yuhan CorporationCompletedHypertension | DyslipidemiaKorea, Republic of
-
PhytoHealth CorporationCompleted
-
Volcano CorporationCompletedCoronary Artery Disease | Coronary Stenosis | Cardiac IschemiaUnited States, Netherlands, Spain, United Kingdom, Japan, Germany, Ireland
-
Masimo CorporationCompleted
-
Masimo CorporationCompleted
-
Masimo CorporationWithdrawn
-
Incyte CorporationTerminatedAlopecia AreataUnited States
-
Masimo CorporationCompleted
-
BioFirst CorporationCompleted
-
Allievex CorporationCompletedMucopolysaccharidosis Type IIIB | MPS III BUnited States, Taiwan, Spain, Colombia, Germany, United Kingdom, Turkey
-
Huami CorporationUnknownAtrial FibrillationChina
-
Volcano CorporationTerminated
-
Volcano CorporationCompletedPeripheral Arterial Disease | Claudication | Critical Limb IschemiaUnited States
-
Masimo CorporationCompletedFalls Injury | Pressure Ulcer | Pressure InjuryUnited States
-
Omeros CorporationUnknownLupus Nephritis | IgAN | C3 Glomerulopathy | MNUnited States, Hong Kong
-
Incyte CorporationCompletedAcute Graft-versus-host DiseaseJapan
-
Haemonetics CorporationCompletedDOAC Eligible SubjectsUnited States
-
LUTRONIC CorporationCompletedWrinkle | Skin Laxity | Skin Texture DisorderUnited States
-
LUTRONIC CorporationUnknownBenign Pigmented LesionsUnited States
-
Incyte CorporationTerminatedSickle Cell DiseaseUnited States
-
Incyte CorporationTerminatedSolid TumorsUnited States
-
Yuhan CorporationCompletedAcute Coronary Syndrome | Carotid Atherosclerotic Plaque With InflammationKorea, Republic of
-
Cordis CorporationNo longer available
-
Spectranetics CorporationCompletedPeripheral Arterial DiseaseUnited States
-
Masimo CorporationCompleted
-
ViroXis CorporationCompletedCommon WartsUnited States